Wave Life Sciences Ltd. Ordinary Shares (WVE) Stock Price

WVEStock

$5.25−49.56%52W

Market Cap$1.03B

P/E—

PEG Ratio—

Div yield—

Beta-1.50

WVE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-72.13%

Price vs S&P 500 (4W)-16.12%

VGM Score36.46

Book Value / Share (Quarterly)$2.35

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)127.06%

Cash Flow / Share (Quarterly)$-1.00

Price vs S&P 500 (YTD)-81.84%

Net Profit Margin (TTM)-309.73%

EPS (TTM)$-1.09

10-Day Avg Trading Volume4.06M

EPS Excl Extra (TTM)$-1.09

Revenue Growth (5Y)16.30%

EPS (Annual)$-1.21

ROI (Annual)-38.84%

Net Profit Margin (5Y Avg)-1070.11%

Cash / Share (Quarterly)$2.54

Revenue Growth QoQ (YoY)-73.88%

ROA (Last FY)-32.01%

Revenue Growth TTM (YoY)-30.42%

EBITD / Share (TTM)$-1.14

ROE (5Y Avg)-134.48%

Operating Margin (TTM)-333.36%

Cash Flow / Share (Annual)$-1.00

P/B Ratio2.28x

P/B Ratio (Quarterly)2.46x

Net Income / Employee (Annual)$-644,700

EV / Revenue (TTM)10.17x

ROA (TTM)-40.06%

EPS Incl Extra (Annual)$-1.21

Current Ratio (Annual)6.47x

Quick Ratio (Quarterly)9.75x

3-Month Avg Trading Volume3.49M

52-Week Price Return-49.56%

Revenue / Employee (TTM)$206,200

Tangible BV / Share (Quarterly)$-0.33

P/S Ratio (Annual)24.17x

Asset Turnover (Annual)0.07x

52-Week High$21.73

Operating Margin (5Y Avg)-1086.85%

EPS Excl Extra (Annual)$-1.21

CapEx CAGR (5Y)-11.73%

26-Week Price Return-60.89%

Quick Ratio (Annual)6.38x

13-Week Price Return-20.25%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.99x

Enterprise Value$664.52M

Revenue / Share Growth (5Y)-13.13%

Asset Turnover (TTM)0.13x

Book Value / Share Growth (5Y)6.05%

Revenue / Employee (Annual)$134,800

Pretax Margin (Annual)-478.33%

Cash / Share (Annual)$3.21

3-Month Return Std Dev59.09%

Net Income / Employee (TTM)$-638,700

ROE (Last FY)-38.84%

EPS Basic Excl Extra (Annual)$-1.21

Receivables Turnover (TTM)52.19x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.09

Receivables Turnover (Annual)31.67x

ROI (TTM)-49.87%

P/S Ratio (TTM)15.79x

Pretax Margin (5Y Avg)-1066.60%

Revenue / Share (Annual)$0.25

Tangible BV / Share (Annual)$-0.43

Price vs S&P 500 (52W)-67.87%

Year-to-Date Return-69.88%

5-Day Price Return-3.21%

EPS Normalized (Annual)$-1.21

ROA (5Y Avg)-50.01%

Net Profit Margin (Annual)-478.33%

Month-to-Date Return-7.08%

Cash Flow / Share (TTM)$-0.78

EBITD / Share (Annual)$-1.26

Operating Margin (Annual)-504.09%

ROI (5Y Avg)-134.48%

EPS Basic Excl Extra (TTM)$-1.09

P/B Ratio (Annual)5.91x

Pretax Margin (TTM)-309.73%

Book Value / Share (Annual)$2.80

Price vs S&P 500 (13W)-23.04%

Beta-1.50x

Revenue / Share (TTM)$0.32

ROE (TTM)-49.87%

52-Week Low$5.01

vGradeC

gGradeD

mGradeD

vgmGradeD

WVE Earnings Surprise History

Q2 25-0.31est. -0.28

Q3 25-0.32est. -0.30

Q4 25-0.30est. -0.26

Q1 26-0.13est. -0.31

Q2 26-0.34est. -0.30

WVE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.25

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
WVEWave Life Sciences Ltd. Ordinary Shares	C	D	D	$5.25
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Wave Life Sciences Ltd. Ordinary Shares

WAVE Life Sciences is a clinical-stage biotech company developing RNA medicines to treat rare and prevalent diseases using its proprietary PRISM platform. The platform combines multiple RNA-targeting modalities—RNA editing, antisense silencing, and RNA interference—with chemistry innovation and genetic insights to optimize drug design and delivery. WAVE's pipeline targets major market opportunities including obesity, Duchenne muscular dystrophy, Huntington's disease, and alpha-1 antitrypsin deficiency.